Skip to main content

Director of Translational Research

Roozbeh Ghaffari

Roozbeh Ghaffari

Director of Translational Research, Research Associate Professor, Department of Biomedical Engineering at Northwestern's McCormick School of Engineering

Email Roozbeh Ghaffari

Dr. Roozbeh Ghaffari obtained his BS and MEng degrees in electrical engineering from the Massachusetts Institute of Technology in 2001 and 2003. He received his PhD degree in biomedical engineering from the Harvard Medical School-MIT Program in Health Sciences and Technology in 2008. Upon completion of his PhD, Dr. Ghaffari co-founded MC10 Inc and served as its Chief Technology Officer. In this role, Dr. Ghaffari led the development and launch of the BioStamp® and the My UV PatchTM wearable products. Dr. Ghaffari also served as a Research Scientist in the MIT Research Laboratory of Electronics where he mentored graduate students in auditory neuroscience research and advised startups competing in the MIT 100K Business Plan contest. His contributions in soft bioelectronics, micro/nano-scale systems, and neuroscience have been recognized with the Helen Carr Peake PhD Research Prize (2008), the MIT100K Grand Prize (2008), the Harvard Business School Social Enterprise Grand Prize (2008), MIT Technology Review Magazine's Top 35 Innovators Under 35 (2013), IEEE Emerging Technology Award (2016), and TEDx Gateway invited speaker (2016). Dr. Ghaffari has published over 70 academic papers and is inventor on over 30 patents. He joined the Center for Bio-Integrated Electronics (CBIE) at Northwestern University in May 2017, where he is currently the Director of Translational Research and Research Associate Professor in the Department of Biomedical Engineering. In his research translation role, Dr. Ghaffari serves on the Editorial Board of Digital Biomarkers Journal, and is Principal Investigator/Advisory Board Member of Neurolux, Rhaeos, Wearifi, and the University of Vermont BME Department. He is also co-founder and CEO of Epicore Biosystems, a CBIE spin-out commercializing wearable microfluidics technology.

Back to top